World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: SLCTR
Last refreshed on: 27 April 2013
Main ID:  SLCTR/2008/016
Date of registration: 22/08/2008
Primary sponsor: South Asian Clinical Toxicology Research Collaboration
Public title: Improvement following acute paraquat poisoning due to antioxidant therapy
Scientific title: Efficacy of antioxidant therapy in acute paraquat poisoning
Date of first enrolment: 1/8/2008
Target sample size: 40
Recruitment status: Completed
URL:  http://www.slctr.lk/trial_details.asp?reg_id={B56916D6-C46F-4A40-B734-03EA6ED28F7B}
Study type:  Interventional
Study design:  Double blind randomize controlled trial  
Countries of recruitment
Sri Lanka
Contacts
Name: Dr Sudheera Jayasinghe 
Address:  Faculty of Medicine, University of Ruhuna
Telephone: +94 91 2246877
Email: sudheerasj@yahoo.com
Affiliation:  Probationary Lecturer
Name: Dr Sudheera Jayasinghe 
Address:  Faculty of Medicine, University of Ruhuna
Telephone: +94 91 2246877 or +94 77 2988312
Email: sudheerasj@yahoo.com
Affiliation:  Probationary Lecturer
Key inclusion & exclusion criteria
Inclusion criteria: Consecutive patients who get admitted to General Hospital, Matara following history of acute exposure to paraquat and symptoms suggestive of acute exposure to paraquat will be selected for the study
Exclusion criteria: • Unconscious patients
• Pregnant mothers


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Acute paraquat intoxication
Intervention(s)
Apart from the standard management (Fernando, 1998), patients will be given intra venous vitamin C as follow, 100 mg, 500 mg, 1000 mg, 3000 mg/day and 3000 mg/ 8 h for 5 consecutive days. S. Y. Hong et al (2002) stated that white blood cell count (WBC), serum Aspartate amino transferase (GOT) and arterial blood PaO2 were significantly decrease (from 9* 103 ± 564 mm3 to 8.5* 103 ± 347 mm3; pless than0.05, from 27.0 ± 3.8 IU to 22.0 ± 2.7 IU; pless than0.01 and from 99.5 ± 3.4 mmHg to 87.3 ± 7.1 mmHg ; pless than0.001 respectively) during the observation period after administration of Intravenous vitamin C. They also noted that when the amount of vitamin C increased to 3000 mg, patients complained pain around the injection site(Hong et al., 2002). Therefore after each dose pulse rate, blood pressure, respiratory rate, body temperature will be monitored every 6 hours and white blood cell count (WBC), liver and renal function tests, urine analysis and oxygen saturation will be conducted every day. In the treatment of paracetamol poisoning N-acetylcysteine (NAC) is given in an initial dose of 150 mg/kg in 200 ml 5% dextrose over 15 minutes followed by 50 mg/kg in 500 ml 5% dextrose over four hours and 100 mg/kg in one litre 5% dextrose over the next 16 hours (total dose 300 mg/kg in 20 hours) (Fernando, 1998; L F Prescott, 1979) But rashes and anaphylaxis are known adverse effects of N-acetylcysteine with the dose given in paracetamol poisoning. Therefore I would like to propose a regimen for NAC which can be used in paraquat intoxication. Proposed NAC regimen for paraquat intoxication will be as follow; Initially 20 mg/kg in 200mL of 5% dextrose over 15 minutes Followed by 50 mg/kg in 500mL over 12 hours (and#8776; 4 mg/h/kg) twice per day for 3 days The total dose will be 320 mg/kg in 72 hours
Primary Outcome(s)
Improvement of total antioxidant status in plasma after administration of Intra Venous vitamin C+placebo or vitamin C + NAC
Secondary Outcome(s)
Improvement of survival
Secondary ID(s)
None
Source(s) of Monetary Support
South Asian Clinical Toxicology Research Collaboration
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history